Tag Archives: Truvada

The Washington Post reports: A long-acting drug injected every two months is more effective at preventing HIV than the pills most commonly used by people at risk of acquiring the infection, according to research released Tuesday at an international AIDS conference. The drug cabotegravir was tested on more than 4,500 cisgender men who have sex with men and transgender women …

The Washington Post reports: Facebook has quietly started removing some misleading ads about HIV prevention medication, responding to a deluge of activists, health experts and government regulators who said the tech giant had created the conditions for a public-health crisis. The ads at issue — purchased by pages affiliated with personal-injury lawyers and seen millions of times — linked drugs …

The Washington Post reports: In 2005, Gilead Sciences notified federal regulators that it was suspending development of a potentially safer, more potent HIV-fighting drug than the one on the market. The company did not restart its Food and Drug Administration application until 2010. Now the five-year delay of a promising drug is at the core of accusations by advocates that …

The New York Daily News reports: Victory is in sight. City officials say they are on the cusp of the once unthinkable — ending the HIV/AIDS epidemic as new medicines and treatment drove down the number of new cases to a 17-year-low in 2018, Health Department stats show. And officials say it’s all thanks to the emergence of a new …

The New York Times reports: The Trump administration on Wednesday sued Gilead Sciences, a pharmaceutical company that sells H.I.V.-prevention drugs that can cost patients up to $20,000 a year, accusing the company of earning billions from research funded by taxpayers without paying taxpayers back. The government said the company infringed upon patents owned by the Department of Health and Human …

NBC News reports: Gilead Sciences, the drug giant behind the blockbuster HIV prevention pill Truvada, won FDA approval on Thursday to market Descovy — a medication already used by those who have HIV — as its next-generation prevention drug. The final approval follows an August vote in favor of Descovy as a pre-exposure prophylaxis medication, or PrEP, by an FDA …

The Washington Post reports: The chairman of the House Oversight Committee is expanding the committee’s review of Gilead Science’s patent claims relating to Truvada for PrEP, the company’s drug that prevents HIV infection. In a letter released Thursday, Rep. Elijah E. Cummings (D-Md.) demanded emails and other information from Gilead about negotiations that led to Gilead’s pledge to donate free …

The Washington Post reports: The chief executive of Gilead Sciences, the nation’s leading manufacturer of HIV drugs, insisted before a House committee Thursday that a government patent on Truvada, a key drug that prevents the infection, is invalid. “Our well-supported view is that the U.S. government does not hold valid patents on the use of Truvada for pre-exposure prophylaxis (‘PrEP’), …

Via press release: Health and Human Services Secretary Alex M. Azar II announced today that, as a result of discussions between the Trump Administration and Gilead Sciences, Inc., the pharmaceutical company has agreed to donate pre-exposure prophylaxis (PrEP) medication for up to 200,000 individuals each year for up to 11 years. PrEP is used to reduce the risk of HIV …

NBC News reports: Thirty-five percent of gay and bisexual men at high risk of HIV infection were using PrEP, or pre-exposure prophylaxis, the daily pill that prevents HIV infection, in 2017, according to data released Thursday by the Centers for Disease Control and Prevention. In 2014, just 6 percent of these men used PrEP. However, despite the nearly 500 percent …

Gay Star News reports: Britain’s High Court today ruled to overturn pharmaceutical company Gilead Science’s patent extension on Truvada. The HIV medication is also used for PrEP (Pre-Exposure Prophylaxis). When taken as advised, this stops HIV negative people acquiring HIV. PrEP is not yet available on the NHS in England and Wales. The NHS is currently conducting a trial to …

This will be a lifesaver for many people: The Food and Drug Administration on Friday announced its approval of Teva’s abbreviated new drug application the first generic of Gilead’s Truvada (emtricitabine and tenofovir disoproxil). The drug is indicated both as a treatment for HIV-1 in combination with other antiretroviral drugs and for pre-exposure prophylaxis to prevent sexually acquired HIV infection …

News-Medical reports: The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today. The study, sponsored by the National Institutes of Health, will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every 8 weeks can safely protect men and transgender women from HIV infection at least as well as the anti-HIV …

But it’s not a complete win. Reuters reports: A high court judge ruled on Tuesday that an HIV pill to prevent infection can be funded by the state health service in England, in a victory for AIDS campaigners who have been calling for its widespread use. So-called pre-exposure prophylaxis (PrEP) against HIV, using Gilead Sciences’ medicine Truvada, can cut the …

But not AIDS itself. The Sydney Morning Herald reports: Australia’s peak AIDS organisations and scientists have announced an end to the AIDS epidemic, as the country joins the few nations in the world to have beaten the syndrome. The number of annual cases of AIDS diagnoses is now so small, top researchers and the Australian Federation of AIDS Organisations have …

Via Pink News: The newest winner of RuPaul’s Drag Race, Bob the Drag Queen, is urging people to take the anti-HIV medication, PrEP. The Pre-Exposure Prophylaxis (PrEP) drug Truvada can reduce people’s chances of being infected with HIV by up to 99 percent, if taken daily. In the latest HIV Beats video by the #endHIV campaign, Bob says: “Oh hey! …

The BBC reports: NHS England has reiterated it will not fund a “game-changer” drug treatment that can prevent HIV, angering HIV charities which had been campaigning to reverse the decision. The NHS is standing firm and says it has no responsibility to provide the treatment, known as Prep. It says the onus should fall on local authorities instead. Charities have …

Patrick Strudwick reports at Buzzfeed: The NHS in England is to reconsider its controversial decision not to provide the drug that prevents HIV, BuzzFeed News can reveal. Faced with the threat of legal action by one of Britain’s leading HIV charities, NHS England’s lawyers have said that a dedicated committee will meet next month to look again at the pronouncement. …

Patrick Strudwick reports at Buzzfeed: HIV charities are shocked and angry over a “shameful” NHS statement released on Monday announcing that the drug that prevents HIV infection will not be made widely available on the NHS. NHS England published a decision on its website on Monday — following an 18-month consideration period — outlining its reasons for not funding Truvada …

Some of the most ardent proponents of PrEP have warned that few medications are 100% effective. Today, sadly, comes proof. Poz.com reports: Researchers have for the first time documented a case of an individual contracting HIV, a multi-drug resistant strain, while apparently adhering well to the daily regimen of Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP). The scientists concluded that it …